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ABSTRACT 
This work aims to develop functionalized, water-soluble indium-based quantum dots 
(QDs) as a non-viral gene therapy vector. The QDs were solubilized in water by 
exchanging native hydrophobic surface ligands with 11-mercaptoundecanioc acid 
(MUA); an amphiphilic ligand providing terminal carboxylate groups that impart water 
solubility to the QDs. The aqueous QDs were then functionalized with a terminal tertiary 
amine to impart a positive surface charge, allowing negatively-charged DNA to complex 
with the nanoparticles. The QDs were characterized via electrophoresis to determine their 
ability to bind DNA. Results show that further work is needed to optimize DNA binding.  
In addition, this work explores QD bioconjugation with lactose as an intracellular 
targeting molecule, to direct QD complexes to the cellular nucleus. Conjugation with 
lactose was confirmed via nuclear magnetic resonance (NMR) spectroscopy. QD probes 
trafficking in N2a (mouse neuroblastoma) cells was visualized using fluorescence 
microscopy and immunocytochemistry (ICC). The images were analyzed via Manders’ 
coefficient to determine the degree of QD colocalization with different organelles inside 
the cell. Results proved inconclusive due to instrumental limitations.  
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CHAPTER 1: INTRODUCTION 
 
1.1 Quantum Dots 
Quantum Dots (QDs) are small semiconducting nanocrystals ranging in size from 
2-20 nanometers (nm) that fluoresce brightly when irradiated with ultraviolet or visible 
light1. QDs are typically composed of group II and VI, or group III and V elements2. 
There are a number of unique advantages to QDs including their small size, size-tunable 
emission wavelength, and increased photostability compared to organic dyes. Current 
work with QDs include applications in solar cells, photodetectors, LEDs, medical 
diagnostics and therapeutics1,3,34,35. The ability to carefully control surface characteristics 
and functionality of QDs makes them an excellent choice for use in biomedical 
applications.  
When irradiated with UV light, electrons in the QD become excited. The excited 
electrons create an exciton pair consisting of an electron and a positive hole. There are 
several modes of relaxation the electron can undergo (Figure 1.1). If the electron 
recombines with the hole, then a photon is released (i.e. fluorescence). This path is 
known radiative relaxation. There are several ways that allow the electron to relax 
without emitting a photon, collectively known as non-radiative relaxation. These include 
relaxation of vibrational or rotational modes and intersystem crossing. If the electron 
undergoes non-radiative relaxation, it can cause the formation of a surface defect, leading 
to trap states. Trap states cause a decrease in overall fluorescence and quantum yield of 
the QDs.  In order to protect the QDs from trap states and surface defects a core/shell 
structure is typically employed.  
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Currently, the most popular QD core/shell system used is cadmium selenide/zinc 
sulfide (CdSe/ZnS). CdSe QDs exhibit intense fluorescence and narrow emission peak 
widths39. Their use in biomedical applications does have some concern due the toxicity of 
Cd2+ ions that may be released through degradation of the QD40. Other core systems can 
be employed to increase biocompatibility of the QDs. In this study, indium-based QDs 
were used, specifically indium phosphide/zinc sulfide, because they possess similar 
characteristics of cadmium-based QDs without the toxicity of Cd2+ ions41. Indium-based 
QDs have lower quantum yield and broader emission peaks, yet are still being used in 
biomedical applications despite these characteristics43.  
 
 
Figure 1.1. Jablonski diagram7. The Jablonski diagram shows different methods of 
relaxation for an excited electron.  
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The fluorescence property of QDs comes from the size of the QD itself. Typical 
indium phosphide (InP) QDs range in size from 2-6 nm4. The fluorescent properties of 
QDs come from the fact that they are smaller in size than the exciton Bohr radius. The 
exciton Bohr radius is defined as the distance between an excited electron and the hole 
left behind after excitation. The result is that the energy levels within the QD become 
discrete, quantized levels and no longer exhibit continuous bandgap properties like bulk 
semiconductors. Another effect of the QD size is a property known as quantum 
confinement in which the band gap of the QDs increase as their physical size decreases5. 
Smaller QDs fluoresce toward the blue end of the spectrum while larger QDs are more 
red shifted (Figure 1.2). This allows for size-tunable emission wavelengths that can be 
tailored to fit the experiment at hand.  
 
 
Figure 1.2. Size-tunable emission of quantum dots6. The emission wavelength of QDs 
depends on the QD size. Quantum confinement allows for discrete energy levels unlike 
bulk semiconductors. The size of the QD and its band gap have an inversely proportional 
relationship. As the size of the QD increases, the band gap increases resulting in a red 
shifted emission wavelength.  
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The core of the QD is susceptible to oxidative degradation as well as the surface 
defects mentioned above. When exposed to UV light in the presence oxygen, the cores 
undergo oxidation8 (Figure 1.3). The oxidation reduces the overall size of the QD and can 
be observed as a blue shifting of the emission fluorescence. If the QDs continue to 
degrade they will eventual cease to fluoresce. In order to prevent surface oxidation, a 
shell is added around the QD core to protect it. Typical shells are composed of zinc and 
sulfur, coating the QD core with about 3-6 monolayers of zinc sulfide (ZnS).  
 
 
Figure 1.38. An example of the process of oxidative degradation of CdSe QD cores. 
When exposed to oxygen and UV light, the QD cores can oxidize. Oxidation of the cores 
can manifest as a blue shifting in fluorescence emission (due to the size decrease in the 
QD size) and/or dimming of the fluorescence intensity. 
 
After synthesis, the QDs have hydrophobic surface ligands, rendering them insoluble 
in water. To be useful in many applications (e.g. biomedical applications) the QDs must 
to be soluble in water. There are three major methods used to impart water solubility: 
which include 1) silica encapsulation, 2) polymer encapsulation, and 3) ligand exchange. 
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Each method has advantages and disadvantages in terms of stability, size increase, and 
technical effort needed.  
Silica encapsulation involves depositing a layer of SiO2 around the QD core. 
Typically, silica precursors are added after core growth to encapsulate the QD and leave 
the hydrophilic SiO2 on the surface
9. The silica coating of the QD not only provides water 
solubility but excellent protection of the core including in acidic environments. The 
downside to silica encapsulation is the uneven coating of silica around the QDs32. 
Variable size distribution pose issues in some applications. 
 Another method of solubilization is polymer encapsulation. In this method, the 
native hydrophobic ligands on the QD surface are used along with an amphiphilic 
polymer to impart water solubility. Trioctylphosphine oxide (TOPO) is a hydrophobic 
ligand often used in QD synthesis and therefore is often found on the QD surface after 
synthesis. Other surface ligands may include long chain amines or thiols such as 
oleylamine or dodecanethiol, respectively. The amphiphilic polymer contains both 
hydrophobic and hydrophilic moieties. The hydrophobic moieties of the polymer interact 
with the native hydrophobic ligands on the QD surface while the hydrophilic moieties are 
exposed to the solvent (Figure 1.4). The hydrophilic surface now provides water 
solubility for the QDs. The amphiphilic polymer can contain chemical handles such as 
carboxyl or amine groups to allow for further modification or bioconjugation of the QD. 
The large polymer allows for a lot of interaction between itself and the QD which, in 
turn, provides good stability in solution over time. Disadvantages of the polymer 
encapsulation method include the increased size of the QDs, and the possibility of 
encapsulating multiple QDs together. That is, with the large polymers typically used in 
6 
this reaction, it is possible to wrap multiple QDs together instead of creating single 
encapsulated QDs.  
 
 
Figure 1.4. Water solubilization of QDs via polymer encapsulation. The native ligands on 
the QD surface interact with the hydrophobic portion of the amphiphilic polymer in order 
to impart water solubility to the QDs. The exposed hydrophilic portion of the polymer 
contains various chemical handles the can be used to further modify the QDs. 
 
Another method of water solubilization is ligand exchange. The native 
hydrophobic ligands on the QD are datively bonded to the QD surface. In ligand 
exchange, amphiphilic ligands are introduced to compete for binding on the QD surface 
(Figure 1.5-1.6). Thiols are often used because they bind well to zinc in the QD shell. The 
sulfur in the thiol ligands forms a stronger bond than the oxygen of TOPO, causing the 
TOPO ligands to be replaced. There are several commonly used thiol ligands including 3-
mercaptopropanoic acid (MPA), 11-mercaptoundecanoic acid (MUA), and dihydrolipoic 
(DHLA). Both MPA and MUA are monovalent ligands, meaning that each ligand has one 
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binding spot. One of the downfalls of ligand exchange is the decreased long term stability 
in solutions. The ligands can dissociate from the QDs over time resulting in a loss of 
water solubility. It is possible to avoid this effect by using multidentate ligands, such as 
DHLA, which has two sulfur atoms. Additionally, some research groups have reported 
using tetradentate sulfur ligands to further increase the long-term water solubility of 
QDs10. The resulting QDs after ligand exchange a much smaller size than polymer-
encapsulated QDs. This is key for applications that need the small size of QDs to be 
effective. The biggest advantage of ligand exchange over the other techniques is that the 
surface chemistry of the QDs can be highly controlled. This leads to more uniform QDs 
without variations in size or surface moieties.  
 
 
Figure 1.5. Water solubilization of QDs via ligand exchange. The native hydrophobic 
ligands on the QD surface are exchanged for hydrophilic ligands in a biphasic reaction. 
The terminal ends of the new ligands allow for further chemical modification as well as 
imparting water solubility. This example shows native oleylamine ligands being 
exchanged with MPA.    
 
 QD  QD 
8 
 
 
Figure 1.6. Ligand exchange phase transfer of QDs27. As the solution stirs, native QD 
ligands exchange for hydrophilic ligands in the aqueous layer. Overtime all the QDs 
move from the bottom organic layer to the upper aqueous layer. 
 
1.2 Gene Therapy 
Gene therapy is a powerful tool that has been used in an attempt to treat many 
genetic diseases11,12. Gene therapy uses a delivery vector to deliver therapeutic DNA to 
cells to replace missing or mutated genes. Viruses are a common vector in gene therapy 
because of their innate ability to deliver DNA into cells. There are also many non-viral 
techniques being researched due to the safety concerns of using viral vectors13.  
Currently, the most common therapeutic technique is viral gene therapy. Many 
types of viruses are used; retroviral vectors are the most common of all viral vectors12. In 
order for the virus to safely deliver the therapeutic gene, the genome of the virus is 
modified to remove infectious or damaging DNA sequences. Even though viral vectors 
are extremely efficient at delivering DNA, there are a number of safety concerns 
associated with them. One of the first clinical trials using viral gene therapy was 
conducted in 1992 in Italy for the treatment of hereditary diseases. Many years after 
treatment, patients began suffering from leukemia, and concerns over the safety of gene 
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therapy were raised11,12. Many viral gene therapy clinical trials were temporarily halted 
until safety concerns could be addressed36,37,38. The problem is that even though viral 
vectors could deliver the DNA there was no way to control where the DNA was inserted 
into the patients genome. Improper insertion of the exogenous DNA could lead to the 
disruption of healthy gene expression12. For example, if a gene controlling the cell cycle 
was disrupted, the cell could become cancerous.  
There are a number of non-viral gene therapy methods that have been explored as 
a way to alleviate some safety issues of using viral vectors. Lipoplexes or polyplexes are 
materials that are used to deliver therapeutic DNA. These vectors condense and protect 
DNA with the respective organic complexing agent. Lipoplexes are cationic lipids that 
electrostatically interact with DNA and cause condensation of DNA with the lipid. The 
lipid:DNA complex is thought to enter the cell through endocytosis where it must then 
diffuse into the cytosol14,15. Polyplexes work in a similar way except they involve using a 
positively charged polymer (e.g. polyethylenimine, PEI) to complex the DNA. 
Polyplexes tend to be amorphous in shape and polydisperse in size, causing them to be 
more difficult to characterize. QDs that are inherently positively charged are a possible 
solution to the irregularity of lipoplexes and polyplexes.  
Although non-viral vectors are safer than their viral counterparts, there are still 
several issues that must be overcome. Non-viral vectors are not nearly as efficient at 
delivering DNA to the nucleus of a cell. The most common method of entry into the cell 
is through endocytosis16. Two types of endocytosis, clathrin-mediated or caveolin-
mediated, are believed to be the major ways in which the vectors are internalized. Upon 
internalization, the vectors are in vesicles known as endosomes. The exogenous material 
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is sorted into specific vesicles, depending on the identity of the material, and then 
vesicles are trafficked through different routes in the cell. The least favorable outcome for 
therapeutic DNA is trafficking to the lysosomes. Lysosomes have a low pH (e.g. 4-5) and 
contain nucleases that will degrade any therapeutic DNA. In order to avoid lysosomal 
trafficking of the therapeutic DNA, there needs to be a way to direct the trafficking away 
from the lysosomes (e.g. via a targeting molecule). Previous work has shown non-viral 
vectors that incorporate sugar molecules may be trafficked toward the Golgi31. This is 
promising because the lumen of the ER is contiguous with the space between the inner 
and outer nuclear membranes 
The use of QDs as a non-viral vector allows for a great variety of surface 
modifications to mediate cellular uptake and trafficking. Molecules can be conjugated to 
the QDs to act as targeting agents or change the chemistry of the surface (e.g. reducing 
surface charge). This work explores the use of lactose as a targeting agent and the 
addition of poly(ethylene) glycol (PEG) polymers to increase uptake and reduce non-
specific binding17,18. 
 
1.3 Lactose and Galectin-3 
Lectins are carbohydrate-binding proteins found in plants and animals. There are 
a number of different lectins in mammalian cells but galectin-3 is of particular interest to 
this work. Galectin-3 is a 31 kDa protein that specifically binds β-galactosides19,20 (i.e. 
sugars containing galactose). The majority of galectin-3 is located within the cytoplasm 
of the cell but some cell types can also express a significant amount within the 
nucleus19,21. Galectin-3 had been shown to enter the nucleus of cells via passive diffusion 
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as well as active transport33. A six amino acid sequence in the protein acts as a nuclear 
localization sequence allowing for active transport through the nuclear pore.  
One common β-galactosides is lactose. Lactose is a disaccharide composed of a 
glucose and galactose sugar. Galectin-3 exhibits a high affinity for lactose and N-
acetyllactosamine19,21. Lactose can be conjugated to the QD through the use of chemical 
handles on the QD surface (i.e. carboxylate groups). The alcohol groups of the lactose 
can be reacted with the carboxylate groups on the QD surface to form stable ester bonds. 
We propose using lactose as a targeting molecule to help deliver QD:DNA conjugates to 
galectin-3. The complex may be trafficked toward the nucleus of the cell using native 
cellular trafficking.  
 
1.4 Cell Culture 
In order to perform the in vitro studies employed in this project, it was necessary 
to maintain stable cell lines of mammalian cells. All work with these cells needs to be 
performed in a sterile environment to prevent contamination. Equipment and solutions 
must be kept sterile; therefore, all cell culture studies were done in a bio-safety cabinet. 
An autoclave was used to sterilize all hardware used in cell culture experiments. 
Disposables (e.g. cell flasks, pipette tips, etc.) brought into the bio-safety hood were 
wiped with a 75% ethanol solution to ensure proper sanitation. Cells were kept in an 
incubator at a constant 37 °C to ensure optimal growth. A bicarbonate-buffered media 
was used to maintain a constant pH in the cell culture flask; therefore, the incubator also 
maintained an atmospheric concentration of CO2 at 5 %. The presence of phenol red in 
the cellular media allows quick assessment by color to roughly indicate the pH. It is a 
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bright pink color above pH 8.2; red at physiological pH, and orange-yellow as the pH 
approaches 6.8.  Proper techniques must be used to ensure viability of the cells for use in 
cellular studies. 
The N2a (mouse neuroblastoma) cell line was used in cellular studies discussed 
herein. The cells were grown in cell culture flasks and split every 2-3 days to maintain 
healthy growing conditions. If the cells become overly confluent they begin growing on 
top of each other instead of in a single monolayer. This may cause differentiation and 
changes in cellular morphology, which would complicate the analysis of intracellular 
trafficking. In overconfluent cells, selective pressure causes the cells best suited to grow 
in unhospitable environments to thrive. The resulting cells no longer represent the model 
cell line that was initially chosen. It is important for the cells to retain the characteristics 
of the chosen model cell line.  
 
1.5 Microscopy 
Microscopy has long been used to study objects which are too small to be seen. 
Light microscopy is a specific type in which visible light is used to detect the sample. 
There are a number of different types of light microscopies, including phase-contrast 
(PC), differential-interference-contrast (DIC), epifluorescence, and confocal microscopy. 
Each type has specific uses along with respective advantages and disadvantages.  
DIC microscopy is a type of brightfield microscopy used to enhance contrast in 
transparent samples such a mammalian cells. In DIC microscopy light first hits a 45° 
polarizing lens followed by a Wollaston prism22. This prism causes the polarized light to 
separate into two orthogonal rays. The two rays then hit a condenser lens that focuses the 
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light onto the sample. The two orthogonal rays will have different optical path lengths 
depending on the refractive index of the sample they are passing through. Once the light 
leaves the sample it passes through the objective lens and a second Wollaston prism. This 
causes the two orthogonal rays of light to recombine. The recombination of light causes 
interference, either constructive or destructive, that brightens or darkens parts of the 
image. Figure 1.7 shows the complete optical path used in DIC microscopy.  
Epifluorescence microscopes are similar to compound microscopes but includes a 
fluorescence light source (e.g. mercury arc lamp) and a set of filter cubes. The filter cubes 
are composed of an excitation filter, dichroic mirror, and emission filter (Figure 1.8). The 
excitation filter only allows a narrow range of wavelengths through that correspond with 
the excitation wavelength of the fluorophore. Once passed through the excitation filter 
the light is reflected off a dichroic mirror towards the sample. A dichroic mirror reflects 
light under a certain wavelength and allows wavelengths above the cutoff to go through. 
 
 
Figure 1.7. Light path in DIC microscopy23. This image shows the light path during DIC 
microscopy. Unpolarized light first hits a polarizing lens resulting in 45° polarized light. 
The light then hits a Wollaston prism separating it into two orthogonal rays. A condenser 
lens focuses the light through the sample. An objective lens focuses the light coming 
through the sample onto a second Wollaston prism which leads to a final polarizing lens. 
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This light is then directed towards and irradiates the sample on the microscope stage and 
excites electrons of the fluorophores in the sample. The emitted light from the 
fluorophore that is directed towards the objective travels back towards the dichroic mirror 
and through an emission filter that removes any stray light. Each fluorophore that is 
visualized needs its own set of filters. This allows many different fluorophores to be 
visualized in one sample without overlap.  
Confocal microscopy is a powerful tool that is often used to study biological 
samples, such as cells. The light source used in confocal microscopy is a laser. Laser light 
has a very narrow wavelength bandwidth, making it excellent for exciting specific  
fluorophores. In normal fluorescence microscopy, the sample is irradiated with light 
evenly throughout. Confocal microscopy makes use of two spatial pinholes that block out 
of focus light (Figure 1.9). The result is that the only light detected originates from one  
 
 
Figure 1.8. Filter cube for fluorescent microscopes24. This figure shows the light path 
through a filter cube. An excitation filter only allows the specified wavelength through. A 
dichroic mirror directs light toward the sample. Light emitted from the sample travels 
through the dichroic mirror and through an emission filter to the objective.   
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focal plane of the sample. A stage controller can be used to make very small focal plane 
“steps” up through the cell at increments as low as 400 nm and record many image 
planes, which collectively are known as a z-stack of the sample. These images can be 
processed to create a 3D image of the sample (Figure 1.10). 
In order to determine if two different signals come from the same location in the 
sample co-localization analysis must be done. A number of different analyses have been 
developed to determine the co-localization between the signal detected for two different 
fluorophores in a sample.26 (e.g. Pearson’s correlation coefficient and Manders’ overlap 
coefficient). There are advantages and drawbacks of each technique; therefore, it is 
critical to choose one best suited to the sample and the analysis performed. For this work, 
Manders’ co-localization coefficient (MCC) was used to determine the degree of overlap 
between the signals detected between the QDs and an organelle fluorescently labeled in 
the cell. The overlap between two fluorophores (e.g. red and green) can be expressed as 
two different equations in MCC analysis: 
𝑀1 =
∑𝑅𝑖,𝑐𝑜𝑙𝑜𝑐
∑𝑅𝑖
 
𝑀2 =
∑𝐺𝑖,𝑐𝑜𝑙𝑜𝑐
∑𝐺𝑖
 
M1 denotes the fraction of red (R) pixels that overlap with green pixels, while M2 
denotes the fraction of green (G) pixels that overlap with red pixels26. In this study, QDs 
fluoresce red and cellular organelles of interest were labeled green. For this reason, 
analysis herein uses M1 to indicate the overlap of QDs with the organelle of interest. That 
is, QD-containing pixels that overlap with organelle-labeled pixels is the objective of the 
colocalization analysis, not the overlap of organelle-labeled pixels that overlap with QD 
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pixels (i.e. we are most interested in the presence and location of QDs, not the presence 
and location of organelles). 
 
 
Figure 1.9. Light path comparison of conventional and confocal microscopy44. (A) 
Conventional microscopy allows light from different planes to be visualized at once. (B) 
Confocal microscopy makes use of two pinholes that block all background light. Only 
light from the plane being observed passes through to the detector. This allows for many 
planes to be imaged and formed into a 3D image.  
 
 
 
Figure 1.10. Z-Stacking25. Using confocal microscopy it is possible to take images of a 
number of different planes in the sample. Software can be used to merge the image (z-
stacks) into a 3D image of the sample.  
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CHAPTER 2: EXPERIMENTAL 
 
2.1 Chemical List 
All chemicals were purchased from Sigma-Aldrich and used as is unless specified 
otherwise. Agarose (MidSci, Cat. No. Be-A125), 3-(dimethylamino)-1-propylamine (Cat. 
No. D158003), 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride 
(DMTMM) (Cat. No. 749613), hexanes (EMD Millipore, Cat. No. 110-54-3), 3-(N-
morpholino) propanesulfonic acid (MOPS) (Fisher, Cat. No. BP308-500), 
paraformaldehyde (PFA) (Cat. No. 158127), poly(ethylene glycol) derivatives ((Creative 
PEGworks, H2N-PEG2000-CH3 (“mPEG”) (Cat. No. PLS-269), H2N-PEG2000-COOH 
(“cPEG”) (Cat. No. PLS-930)), Triton X-100 (Astoria Pacific, Cat. No. 90-0770-04), 
boric acid (Cat. No. B7901), sodium tetraborate decahydrate (Cat. No. S9640), 11-
mercaptoundecanoic acid (MUA) (Cat. No. 450561 and Chem Cruz, Cat. No. sc-
251618), tetramethyl ammonium hydroxide (TMAH) (Acros, Cat. No. 207520250), 
acetone (Fisher, A1320), Toluene (Fisher, T324), ethanol (Ultra Pure, Cat. No. 16A4E), 
20K MWCO dialysis units (Fisher, Cat. No. 69590). 
For cell culture and subsequent immunocytochemistry, the following reagents 
were used. Dulbecco’s-Modified Eagle’s medium (D-MEM) (Thermo Scientific, Cat. No. 
SH30022.01), Opti-MEM reduced serum medium (Life Technologies, Cat. No. 51985-
034), rabbit anti-giantin antibody (Golgi Apparatus Marker, Abcam, Cat. no. ab24586), 
rabbit anti-lamin antibody (Nuclear envelope marker, Abcam, Cat. No. ab16048), rabbit 
anti-GRP78 BiP antibody (Endoplasmic reticulum marker, Abcam, Cat. No. ab21685), 
rabbit anti-Rab5 antibody (Endosome marker, cell signaling tech., Cat. No. 35478), rabbit 
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anti-lamp1 antibody (Lysosome marker, Abcam, Cat. No. ab24170), anti-rabbit Alexa488 
conjugated antibody (Life Technologies, Cat. No. A21441), fetal bovine serum (Hyclone, 
Cat. No. SH30396.02) antibiotic/antimitotic solution 100X (Penicillin G, Streptomycin, 
and Amphotericin B) (Hyclone, Cat. No. SV30079.01), trypsin (Hyclone, Cat. No. 
AV30031.01), trypan blue (Hyclone, Cat. No. AV30084.01) and SYBR® Safe (Life 
Technologies, Cat. No. S-33102), 12 well plate (Corning, Cat. No. 353043), 18mm 
coverslips (Fisher, Cat. No. 12-545-84), N2a (mouse neuroblastoma) cells were a kind 
gift provided by Dr. Tania Q. Vu at Oregon Health and Science University. 
 
2.2 Water Solubilization of QDs 
After synthesis, QDs are only soluble in organic solvents (e.g. hexanes). To be 
useful in biological applications the QDs need to be soluble in water. There are several 
different approaches that can be used, as previously discussed in Chapter 1.1. Studies 
herein used ligand exchange to impart water solubility on the QDs.  
 Early attempts at water solubilization were conducted using dihydrolipoic acid 
(DHLA) as the solubilizing ligand. Lipoic acid had to be reduced to DHLA before being 
useful for water solubilization. Lipoic acid (1 g) was dissolved in 0.25 M sodium 
bicarbonate buffer. Slowly, 1.1 molar equivalent of sodium tetraborohydride was added 
and allowed to react for 1 hour. The solution was then acidified with 1 M HCl and the 
DHLA was extracted using chloroform. The chloroform was removed via rotovap leaving 
DHLA.  Before beginning, the QDs were washed to remove any excess hydrophobic 
ligands in solution after synthesis. For washing, 1 mL of acetone was added to 
approximately 500 µL of 7 µM QDs (obtained from Matt Ellis, notebook number MAE-
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001-45) in a 1.5 mL Eppendorf tube. The solution is then spun in a centrifuge at 5000 x g 
for 5-10 minutes, causing precipitated QDs to form a pellet at the bottom of the tube. The 
supernatant was discarded and the pellet was dissolved in 500 µL of chloroform or 
hexanes. This washing process was repeated for a total of three times with the last step 
being to not dissolve the QDs (left as a pellet in the tube). Next, 500 µL of DHLA and 
500 µL of ethanol was added to the tube containing the pellet of QDs. A small stir bar 
was added and the solution was stirred at 60 °C in a water bath for 6-8 hours. After this 
reaction period, the solution was moved to a 15 mL Falcon tube. 4.1 mL of an 
ethanol/hexane/chloroform (2 mL ethanol, 2 mL hexane, 0.1 mL CHCl3) mixture was 
added to the Falcon tube. Hexane was slowly added until the solution became turbid (2-3 
mL). The turbid solution was then centrifuged for 15 minutes at 3000 x g. The 
supernatant was discarded and the QD pellet was dissolved in 250 µL of water. A 50K 
MWCO centrifugal filter was used to further purify the QDs before determining the 
concentration as discussed later.  
A study published in ACS Nano27 provided a possibly easier method to impart 
water solubility on the QDs. The QDs suspended in organic solvent was simply mixed 
with amphiphilic ligands in an aqueous solution, with TMAH to aid in the phase transfer 
between organic and aqueous phases. The biphasic solution was rapidly stirred forming 
an emulsion. As the native hydrophobic ligands exchanged for hydrophilic ligands the 
QDs move from the organic layer to the aqueous layer. The method discussed earlier, 
using DHLA, was eventually replaced in favor of this simpler method.  
 11-mercaptoundecanoic acid (MUA) was chosen as the solubilizing ligand for this 
experiment due its availability and ease of use. As before the QDs were thoroughly 
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washed prior to use using the acetone precipitation method described above. The final 
wash step was to dissolve the QD pellet in CHCl3. A 0.5 M solution of 
tetramethylammonium hydroxide (TMAH) was made by dissolving 0.453 g of TMAH in 
5 mL of DI water. A 0.2 M solution of MUA was made by dissolving 0.218 g of MUA in 
the 0.5 M TMAH solution. The MUA was dissolved in the basic TMAH solution to 
deprotonate the thiol and allow better binding to the QD surface1. Equal volumes of QDs 
and 0.2 M MUA were added together and vigorously stirred for 12-24 hours. Volumes 
anywhere from 0.5 mL to 5 mL have been successfully solubilized using this method. 
After stirring, the QDs moved from the lower organic layer into the aqueous layer on top 
as seen in Figure 1.6. The bottom organic layer was discarded and the aqueous layer then 
contained the QDs. The pH of the QD solution was lowered to ~8 using 0.1 M HCl, 
checked via pH paper. The QDs were then placed at 4 °C overnight to allow any excess 
MUA to precipitate out of solution. After refrigeration, the QDs were spun at 1000x g for 
5 minutes to pellet any precipitated MUA. The QD supernatant was collected and the 
MUA pellet was discarded. To purify the QD solution, it was dialyzed using a 20k 
MWCO dialysis membrane against 0.1 M borate buffer (pH 8.3) for 12-24 hours with 
frequent dialysate changes. After purification, the concentration of the QDs was 
determined by UV/Vis spectrometry using the method described by Xie et. al.42. 
 
2.3 PEGylation of QDs 
 After water-solubilization, the surface of QDs were covered with carboxylate 
terminal groups from MUA surface ligands. To increase cellular uptake and reduce non-
specific binding, the QDs were conjugated with poly(ethylene glycol) (PEG). Two 
21 
different PEG derivatives were conjugated to the QDs: amine-PEG-COOH (“cPEG”) and 
amine-PEG-methoxy (“mPEG”) (Figure 2.1). Primary amine terminal ends of the PEG 
can react with carboxylate groups on the QD surface (via MUA) to form stable amide 
bonds. The carboxylate terminal of the cPEG is then available for further conjugation. 
The methoxy terminal of the mPEG reduces the surface charge of the QD. The ratio of 
mPEG to cPEG can be varied to produce QDs with surface charges dependent on the 
intended application of the QDs. For this experiment a ratio of 1 cPEG to 5 mPEG was 
used. An activator (i.e. DMTMM) was used to allow the reaction between the terminal 
carboxylate groups from the QD and amine groups from the PEGs in mild aqueous 
conditions. Figure 2.2 shows the mechanism of DMTMM activation. The reaction of 
DMTMM with the QDs leaves an excellent leaving group on the QD to allow for reaction 
with a primary amine. 
 
 
Figure 2.1. Chemical Structure of PEG derivatives. (A) amine-PEG-COOH “cPEG”. (B) 
amine-PEG-methoxy “mPEG”.  
 
 First, 1 mg/mL solutions of DMTMM, cPEG, and mPEG are prepared by 
weighing 1 mg of each chemical and dissolving in 1 mL of 0.1 M borate buffer, pH 8.5. 
Next, the DMTMM solution was added (at a 5,000 molar excess of QDs) to an Eppendorf 
containing water soluble QDs. The DMTMM and QDs were allowed to react for 15 
minutes and then transferred to a 20k MWCO dialysis unit. The solution was dialyzed 
against 4 L of 0.1 M borate buffer for 15 minutes to remove any unreacted DMTMM. 
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This step was necessary to avoid the PEG derivatives from undergoing an intramolecular 
reaction. After dialysis, the activated QD solution was placed in an Eppendorf tube and 
solutions of mPEG and cPEG are added. The mPEG was added at a 5,000 molar excess 
and the cPEG is added at a 1,000 molar excess, respective to the QDs. The solution was 
stirred and allowed to react for 3-4 hours. Afterwards, the QDs are dialyzed again against 
0.05 M borate buffer overnight to remove any excess PEGs. To ensure an accurate 
concentration after dialysis, the QDs were placed in a vacufuge and concentrated back to 
the original starting volume. Gel electrophoresis was used to determine success of the 
PEGylation. A 0.4% agarose gel was prepared by dissolving agarose in 0.1M borate 
buffer and heating until boiling. The QD-PEG conjugates and the QD precursor were 
electrophoresed for 30 minutes at 140 V.  
 
 
Figure 2.2. DMTMM activation mechanism28. Figure shows the mechanism by which 
DMTMM activates carboxylate groups. The activated group, shown as “active ester” is 
reactive toward amines in mild aqueous conditions.  
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2.4 Bioconjugation with Lactose 
It is necessary to conjugate a targeting molecule to the QDs to direct trafficking 
within the cell to the desired organelle (nucleus). Once more, DMTMM was used to 
couple PEGylated QDs to lactose. The intended result of the reaction was a stable ester 
bond between terminal carboxylate groups of the PEGylated QDs and a hydroxyl group 
from lactose (Figure 2.3).  
 
 
Figure 2.3. Bioconjugation of PEGylated QDs to Lactose. A. The PEGylated QDs are 
first activated with DMTMM to produce reactive intermediates. B. Lactose is then added 
and a hydroxyl group of lactose reacts with the PEGylated QDs to produce a stable ester 
bond. There are eight hydroxyl groups on lactose; while it is theorized primary alcohols 
are more reactive, it is unknown which hydroxyl reacts with the QD. 
 
A 1 mg/mL solution of DMTMM was used to activate the carboxylate groups of 
the PEGylated QDs. The DMTMM was added at 5,000 molar excess to a solution of 500 
nM PEGylated QDs in an Eppendorf tube and allowed to react for 15 minutes. A 5 
mg/mL solution was lactose is prepared in 0.1 M borate buffer, pH 8.5, and added at 
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5000 molar excess with respect to the QDs. The solution was stirred and allowed to react 
for 4-6 hours. After the reaction was complete the solution was dialyzed in a 20k MWCO 
dialysis unit against 0.05 M borate buffer overnight. A vacufuge was used to concentrate 
the solution back to the original volume of QDs to identify QD concentration. The 
success of the reaction was confirmed by nuclear magnetic resonance (NMR) 
spectroscopy.  
 
2.5 Imparting Positive Charge 
 For the QDs to able to electrostatically bind DNA they must have a positive 
surface charge. After water solubilization the QDs was passivated with MUA; the QD 
surface was negative due to the terminal carboxylate groups of MUA. Therefore, the QDs 
must be functionalized in a way that imparts a positive surface charge while still 
maintaining water solubility. The carboxylate groups on the QD surface were reacted 
with the diamine compound 3-(dimethylamino)-1-propylamine (DMAPA). DMAPA 
contains both a terminal primary amine which can be reacted with carboxylates and a 
terminal tertiary amine that remains unreactive under the reaction conditions. Figure 2.4 
shows the reaction scheme used. As with the other reactions, DMTMM was first used to 
activate carboxylate groups (via MUA) on the QD surface. A 10,000 molar excess of 
DMTMM (relative to the QDs) was added to a 1.5 mL centrifuge tube containing 500 nM 
water-soluble QDs in 0.1M borate buffer, pH 8.5, and allowed to react for 15 minutes. 
Then, a 10,000 molar excess of DMAPA (relative to QDs), diluted to ~0.01M in 0.1M 
borate buffer, was added to the tube containing the QDs. The reaction was stirred for 4-6 
hours and then dialyzed in a 20k MWCO dialysis unit overnight against 0.05M borate 
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buffer, pH 8.5. After dialysis, a vacufuge was used to concentrate the QD solution back 
to the starting volume. Once completed, the success of the reaction was investigated 
using gel electrophoresis.  
 Gel electrophoresis was used to determine the successful addition of DMAPA to 
the QD and the ability of the QD:tert-amine conjugates to electrostatically bind 
polyanionic DNA. The QD:tert-amine conjugates were electrophoresed through a 0.4% 
agarose gel containing SYBR Safe (a green fluorescing DNA dye) in 0.1M MOPS buffer 
(pH 7.0). The QD conjugates were incubated with pDNA (4 µL QDs to 2 µg pDNA) at 
room temperature for 10 minutes before loading into the gel. The samples were 
electrophoresed for 30 minutes at 120V and then visualized with a UV transilluminator.  
 
 
Figure 2.4. Scheme depicting the reaction of QDs with a diamine. A. The QDs were first 
activated with DMTMM. B. DMAPA was added and reacted with the activated 
carboxylate groups. The resulting reaction functionalized the surface of the QD with 
tertiary amines which are protonatable at physiological pH.  
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2.6 Immunocytochemistry and Microscopy 
 A model cell line of N2a cells (Mouse Neuroblastoma, ATCC Cat #HB-12317) 
were used to visualize the cellular trafficking of the QD-PEG-lactose conjugates. Cells 
were grown in media consisting of Dulbecco’s Modified Eagle’s Medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS) along with antibiotic and antimitotic 
solution (100 units/mL Penicillin G, 100 µg/mL Streptomycin, and 0.25 µg/mL 
Amphotericin B). Cells were cultured and passaged every 2-3 days to prevent 
overcrowding within the cell culture flask.  
 N2a cells were plated onto 18 mm circular coverslips in a 12 well plate at a 
density of 40,000 cells/well and allowed to incubate for 24 hours at 37 °C in a 5% CO2 
incubator. When cells reached ~60% confluency, they were incubated with the 
lactosylated QDs. The lactosylated QDs were diluted in cell culture media to a final 
concentration of 8 nM. At this time, spent media in each well was aspirated away, 
replaced with media containing lactosylated QDs, and incubated at 37 °C for 8 hours. 
The cells were then fixed using 4% paraformaldehyde (PFA) in phosphate buffered saline 
(PBS) for 15 minutes. After fixing, the cells were permeabilized with 0.5% Triton X-100 
for 20 minutes and then washed three times with PBS for 10 minutes. At this point, cells 
could be stored at 4 °C indefinitely as long as PBS did not evaporate to dry the 
coverslips. 
 Immunocytochemistry (ICC) was used to label and visualize cellular proteins 
using antibodies. Cellular organelles were labeled using antibodies specific for proteins 
that localize within that particular organelle. To visualize where lactosylated QDs 
localized within the cell, a variety of organelles were labeled. In this study, the organelles 
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labeled were nuclear envelope, Golgi body, endoplasmic reticulum (ER), lysosomes, and 
early endosomes (EE).  
First, fixed and permeabilized cells containing lactosylated QDs were blocked 
with 10% bovine albumin serum (BSA) in PBS for 1 hour. Cells were then incubated 
with primary antibodies at the concentration recommended by the manufacture in 
humidified chambers overnight at 4 °C. The following day, cells were washed three times 
with PBS for 15 minutes and then blocked again for 1 hour with 10% BSA in PBS. The 
coverslips were then incubated with the secondary antibody, anti-rabbit Alexa488 (1-
1000 dilution in 10% BSA in PBS), for 1 hour at room temperature. Following secondary 
incubation, cells were washed three times with PBS for 15 minutes and then stored in the 
12 well plate with 0.1 M borate buffer, pH 8.5. The coverslips could then be placed into a 
magnetic imaging chamber for use in fluorescence microscopy.  
 Both epifluorescence and confocal microscopy were used to visualize QD 
conjugates with the cells. For epifluorescence microscopy, a Zeiss Axio Observer 
microscope equipped with a Zeiss Axiocam MRm CCD camera was used. Two sets of 
filter cubes were used during imaging: Rhodamine (ex545nm/em605nm) and FITC 
(ex470nm/em525nm) (Figure 2.5). The sets of filters in each cube allowed for 
visualization of each fluorophore individually (i.e. Alexa488 and QDs). Figure 2.6 shows 
the excitation/emission spectra for each fluorophore. The FITC filter cube was used to for 
visualizing the Alexa488-conjugated antibodies used for ICC. The rhodamine cube was 
used for visualizing the QD conjugates.  
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Figure 2.5. Filter cube emission and excitation cutoffs. Two filter cubes were used to 
visualize the cells during microscopy. (A) FITC cube – used to visualize Alexa488 
conjugated antibodies. (B) Rhodamine cube – used to visualize QD conjugates. 
 
 
Figure 2.6. Excitation and emission of Alexa488 and QD conjugates29. These spectra 
show the excitation (dotted lines) and emission (solid lines) spectra of each fluorophore. 
The filter cubes used were chosen to remove any overlap between signals. 
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CHAPTER 3: RESULTS AND CONCLUSIONS 
 
3.1 Water Solubilization of QDs 
 Early attempts at imparting water solubility to the QDs were done using 
dihydrolipoic acid (DHLA). The use of a bidentate ligand, in theory, should provide more 
stable water-soluble QDs due to the two binding sites with the QD surface. However, 
many trials resulted in only partial solubilization of the QDs. Some QDs became water-
soluble while others remained soluble only in organic solvents, or precipitated out of 
solution all together. The likely cause of this incomplete transfer of QDs from organic 
solvent to aqueous buffer is due to oxidation of the DHLA. The two sulfhydryl groups of 
DHLA can be oxidized to form an intramolecular disulfide bond, resulting in the 
formation of lipoic acid. Lipoic acid cannot bind to the QD surface because it now lacks 
the sulfhydryl groups required to bind to the QD surface. The work up after solubilization 
was also tedious and not optimized. Different organic solvents (i.e. CHCl3, hexanes, and 
ethanol) had to be added in precise amounts to cause turbidity in the sample. This method 
of water solubilization left a lot of room for error that resulted in incomplete 
solubilization of the QDs.  
 After solubilization trials with DHLA, 11-mercaptoundecanoic acid (MUA) was 
chosen as the solubilizing ligand. The MUA solubilization protocol was a simpler, more 
repeatable method. A solution of MUA was added to the QDs in organic solvent and 
stirred resulting in complete solubilization of the QDs (Figure 3.1). The concentration of 
MUA was optimized and 0.2 M MUA was found to work best. Less MUA resulted in 
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incomplete solubilization of the QDs while more resulted in excess MUA that proved 
difficult to remove.  
 
 
Figure 3.1. Water solubilization of QDs. These images show the successful transfer of 
QDs from chloroform (left image) to an aqueous solution (right image). 
 
Once the QDs were soluble in water, some purification needed to be done to 
remove excess MUA from solution. After solubilization, the QD solution has a pH of 
~11. Adding 0.1 M HCl to lower the pH to ~8 resulted in MUA precipitating out of 
solution. Unbound MUA is not very soluble in a solution below pH 10. The QDs were 
then placed in a refrigerator at 4 °C for several hours, allowing more MUA to precipitate 
from solution. Finally, dialysis overnight was used to remove any MUA left in solution.  
 QDs successfully solubilized by either MUA or DHLA proved to be stable in 
aqueous solution. Samples of MUA-solubilized QDs were stable for several months 
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stored at 4 °C in 0.1M borate buffer. DHLA-solubilized QDs stored at room temperature 
in 0.1 M borate buffer have been stable for over a year.  
 Previous work in our lab was used polymer encapsulated QDs. A benefit to using 
a ligand exchange solubilization (vs. polymer encapsulation) is a decrease in overall size. 
Dynamic light scattering (DLS) was used to determine the hydrodynamic radius of the 
water-soluble QDs. Figure 3.2 demonstrates that QDs solubilized by ligand exchange are 
approximately 4 nm smaller in diameter. Solubilization via ligand exchange also 
produced QDs that were more uniform in size (evidenced by a lower standard deviation 
in hydrodynamic diameter, Figure 3.2). 
 
 
Figure 3.2. DLS size comparison between solubilization methods30. Solubilization via 
ligand exchange method produces smaller, more uniformly sized QDs as compared to 
polymer encapsulation.   
 
3.2 Surface Functionalization of Water Soluble QDs 
 After the InP/ZnS QDs were soluble in water, the terminal carboxylate groups 
(via MUA) were functionalized to reduce non-specific binding and target the QD within 
the cell. To reduce non-specific binding both mPEG and cPEG (Figure 2.1) were 
32 
conjugated to the QDs. Addition of poly(ethylene glycol) was shown in previous work to 
reduce non-specific cellular interactions with the QDs17,18. The addition of PEG was 
accomplished using DMTMM as an activator, and successful PEGylation was confirmed 
via agarose gel electrophoresis (Figure 3.3). PEGylated QDs are larger and have a 
reduced surface charge due to terminal methoxy groups of mPEG; therefore, PEGylated 
QDs to not move as far through the gel as unconjugated QDs. 
 
 
Figure 3.3. Electrophoretic characterization of PEGylated QDs. An agarose gel was used 
to confirm conjugation of PEG to the QDs. Lane 4 shows the PEGylated QDs and lane 5 
shows unconjugated QDs. The PEGylated QDs move slower through the gel due to 
increased size and decreased surface charge.  
 
 Once the PEGylated QDs were confirmed via electrophoretic characterization, 
lactose was conjugated to terminal carboxylate groups of the QD. DMTMM was used as 
an activator to conjugate lactose to the QDs. Hydrogen NMR was used to confirm 
successful conjugation between lactose and the QDs. The peaks of the hydrogens on the 
anomeric carbons of lactose were used to determine successful conjugation. These peaks 
appear as doublets at 4.31-4.33 and 5.08-5.09 ppm, respectively (Figure 3.4). The 
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presence of these peaks in the NMR spectrum of the QD-lactose conjugate confirms 
lactosylation of PEGylated QDs (Figure 3.5).  
 
 
Figure 3.4. 1H NMR of lactose at 400 MHz in D2O. Peaks labeled A and B represent the 
hydrogens on the anomeric carbons of lactose.  
 
 
Figure 3.5. 1H NMR of QD-lactose conjugates at 400 MHz in D2O. Peaks labeled A and 
B depict the anomeric hydrogens of lactose, demonstrating successful conjugation of 
lactose to the QDs.  
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3.3 Imparting Positive Charge 
 To electrostatically interact with pDNA, the QDs must have a positive surface 
charge. A diamine compound, 3-(dimethylamino)-1-propylamine (DMAPA), was chosen 
because of its small size and presence of both primary and tertiary amino groups. The 
primary amine was reacted with the terminal carboxylate groups on the QD surface using 
DMTMM as an activator. The tertiary amine is not reactive under these conditions and is 
protonatable at physiological pH (~7.4), serving as a source of positive charge on the 
QDs. Gel electrophoresis was used to investigate the surface charge of the QD-diamine 
conjugates (here on referred to as “QD-tert-amine conjugates”). The addition of DMAPA 
to the QD surface was expected to impart positive surface charge on the QDs. 
Unconjugated QDs migrated toward the positive electrode, as expected; however, QD-
tert-amine conjugates appeared to remain in the well (Figure 3.6). There are two possible 
explanations for the QD-tert-amine not migrating within the gel: 1) The QD-tert-amine 
conjugates aggregated to the degree that they are too large to move through the gel 
matrix, or 2) the QD-tert-amine have a neutral surface charge and therefore do not 
migrate toward either electrode. To test the second hypothesis, the molar ratio of 
DMTMM was increased in an attempt to activate additional carboxylate groups on the 
QD surface. In theory, if more carboxylate groups are activated, this may allow more 
DMAPA to react, further increasing the positive charge on the QD surface. However, this 
increase in the molar ratio of DMTMM caused the QDs to precipitate out of solution 
during the reaction. It is believed that upon activation of too many terminal carboxylate 
groups the QDs lose water solubility and precipitate from solution. This doesn’t allow 
any further reaction to take place.  
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Figure 3.6. Electrophoretic characterization of QD-tert-amine conjugates. Lane 1 – 
Precursor (control) QDs. Lane 2 – Empty. Lane 3 – QD-tert-amine conjugates. This gel 
shows that the control QDs moved toward the positive electrode as expected. However, 
the QD-tert-amine conjugates remained in the well, and did not migrate toward either 
electrode.  
 
 Electrophoresis was used to investigate any electrostatic interaction between the 
QD-tert-amine conjugates and plasmid DNA (pDNA). The QD-tert-amine conjugates 
were incubated with pDNA for 10 minutes at room temperature and then loaded into the 
gel. SYBR Safe, a green fluorescent dye that intercalates DNA, was added to the agarose 
gel to allow visualization of the pDNA.  
As expected, unconjugated QDs moved toward the positive electrode due to the 
negative surface charge imparted by MUA. (Figure 3.7, lane 1). Much of the QD-tert-
amine conjugates, which were not incubated with pDNA, was retained in the well (lane 
2); however, a small amount of QD-tert-amine conjugates appear as a faint streak toward 
the positive electrode, indicating at least a partial negative surface charge. In lane 3, QD-
tert-amine conjugates incubated with pDNA, did appear to migrate from the well as well. 
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However, the pDNA added to the QD-tert-amine sample appears to have migrated 
independently of the QD-tert-amine, i.e. similar to the migration of pDNA alone (lane 4). 
The independent migration patterns in lane 3 do not indicate an interaction between the 
pDNA and QDs (Figure 3.7). These results seem to indicate that the surface charge of the 
QD is partially negatively charged and therefore is not able to electrostatically complex  
the pDNA.  
 
.  
Figure 3.7. Interaction of QD-tert-amine and pDNA. Lane 1 – Unconjugated QDs. Lane 
2 – QD-tert-amine. Lane 3 – pDNA and QD-tert-amine. Lane 4 – pDNA control. The 
QD-tert-amine and pDNA were allowed to incubate at room temperature for 10 minutes 
prior to loading into the gel. Lane 3 shows that the pDNA appears to not interact with the 
QD-tert-amine conjugates and migrate independently through the gel.  
 
Attempts to increase the positive surface charge of QDs by increasing the molar 
ratio of DMTMM in the DMAPA reaction proved unsuccessful. The increase in 
DMTMM caused the QDs to precipitate from solution. This may be due to the conversion 
of too many carboxylate groups into the active ester intermediate during the reaction. The 
carboxylate groups aid the solubilization of QDs in water due to the presence of the 
negatively charged carboxylate groups. The activated ester (Figure 2.2) does not contain 
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any charged groups and may decrease water solubility causing the aforementioned 
precipitation of QDs during the reaction. 
 
3.4 Cellular Trafficking of QD-Lactose Probes 
 To visualize trafficking of the lactosylated QDs, cells were imaged using 
fluorescence microscopy after performing ICC. The organelles labeled during ICC were: 
the Golgi apparatus, the nuclear envelope, lysosomes, and early endosomes. Control 
coverslips were also imaged that were treated with unconjugated QDs. Both 
epifluorescence and confocal microscopy were used to visualize the trafficking of QDs in 
the cells.  
 Epifluorescence microscopy was used initially to visualize cellular trafficking of 
the lactosylated QDs. Figures 3.8 and 3.9 show cells treated with QDs and 
immunolabeled for the Golgi apparatus. There appears to be some overlap between the 
QDs and Golgi in both cases. However, it is not possible to draw a conclusion on whether 
the two colocalize or not using epifluorescence microscopy. The QDs could be 
colocalized with the Golgi, or the QDs could be localized above or below the Golgi, due 
to the large width of the focal plane in epifluorescence microscopy. Figures 3.10 and 3.11 
depict cells immunolabeled for the nuclear envelope, and Figures 3.12 and 3.13 depict 
cells immunolabeled for the lysosomes. Similar to cells with labeled Golgi apparatus, 
there appears to be some overlap between the labeled organelle and the QDs. To 
quantitatively analyze colocalization, the cells must be imaged using confocal 
microscopy. Confocal microscopy can be used to visualize very thin focal planes within 
the cells to determine colocalization.  
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Figure 3.8. N2a cells incubated with unconjugated QDs and immunolabeled for the Golgi 
apparatus. These images show N2a cells incubated with 6 nM unconjugated QDs for 8 
hours and immunolabeled for the Golgi apparatus. (A) DIC image of N2a cells. (B) the 
Golgi apparatus. (C) QDs. (D) Overlay of Golgi and QDs (E) Overlay of images A-C. 
Bar = 10 m. 
 
 
 
Figure 3.9. N2a cells incubated with lactosylated QDs and immunolabeled for the Golgi 
apparatus. These images show N2a cells incubated with 6 nM lactosylated QDs for 8 
hours and immunolabeled for the Golgi. (A) DIC image of N2a cells. (B) Golgi 
apparatus. (C) Lactosylated QDs. (D) Overlay of Golgi and QDs. (E) Overlay of images 
A-C. Bar = 10 µm. 
A C B 
D E 
A B 
E D 
C 
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Figure 3.10. N2a cells incubated with unconjugated QDs and immunolabeled for the 
nuclear envelope. These images show N2a cells incubated with 6 nM unconjugated QDs 
for 8 hours and immunolabeled for the nuclear envelope. (A) DIC image of N2a cells. (B) 
Nuclear envelope. (C) QDs. (D) Overlay of nuclear envelope and QDs. (E) Overlay of 
images A-C. Bar = 10 µm. 
 
 
Figure 3.11. N2a cells incubated with lactosylated QDs and immunolabeled for the 
nuclear envelope. These images show N2a cells incubated with 6 nM lactosylated QDs 
for 8 hours and immunolabeled for the nuclear envelope. (A) DIC image of N2a cells. (B) 
FITC channel showing the nucleus. (C) Lactosylated QDs. (D) Overlay nuclear envelope 
and QDs. (E) Overlay of images A-C. Bar = 10 µm. 
A 
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A C B 
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Figure 3.12. N2a cells incubated with unconjugated QDs and immunolabeled for the 
lysosomes. These images show N2a cells incubated with 6 nM unconjugated QDs for 8 
hours and immunolabeled for the lysosomes. (A) DIC image of N2a cells. (B) 
Lysosomes. (C) QDs. (D) Overlay of lysosomes and QDs. (E) Overlay of images A-C. 
Bar = 10 µm. 
 
 
Figure 3.13. N2a cells incubated with lactosylated QDs and immunolabeled for the 
lysosomes. These images show N2a cells incubated with 6 nM lactosylated QDs for 8 
hours and immunolabeled for the lysosomes. (A) DIC image of N2a cells. (B) 
Lysosomes. (C) Lactosylated QDs. (D) Overlay of lysosomes and QDs. (E) Overlay of 
images A-C. Bar = 10 µm. 
A C 
E 
B 
D 
A 
D E 
C B 
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 In a second imaging experiment, ICC was used to label different cellular 
organelles, confocal microscopy was used to visualize trafficking of QDs within the cell, 
and Manders’ colocalization coefficients were used to determine the overlap between the 
red channel (QDs) and green channel (organelles). The M1 value was examined instead 
of M2 because M1 focuses on red pixels (QDs) while M2 focuses on green pixels 
(organelle). However, upon examination of the figures, significant bleed-through from 
the green channel into the red channel was observed. That is, some of the signal in the red 
channel originated from the green fluorophore, distorting the results. Because of this 
bleed-through, it was not possible to accurately calculate the amount of co-localization. 
However, the Manders’ coefficient still might hold some useful information if the amount 
of bleed-through was consistent for each image. If so, comparison of M1 values between 
cells incubated with unconjugated QDs and lactosylated QDs may indicate if the 
presences of lactose caused any change in QD trafficking within the cell.  
A z-stack of images can be visualized by creating a what is known as a maximum 
projection. In generating a maximum projection, each pixel in the stack is analyzed and 
the pixel with the highest intensity is chosen to create the final image. Maximum 
projections were created (Figures 3.14 – 3.19) for each imaged cell with internalized 
QDs. While the maximum projection is shown here for visual purposes, the quantitative 
analyses described below used the entire 3-D volume of the cell (i.e. each slice in each 
stack was included in the analysis). 
Manders’ co-localization analysis was performed on three confocal z-stacks to 
calculate an M1 value. M1 values for co-localization between the QDs and the Golgi 
apparatus were 0.502 ± 0.009 for unconjugated QDs and 0.521 ± 0.237 for lactosylated 
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Figure 3.14. 3-D maximum project image used to investigate colocalization between the 
Golgi apparatus and lactosylated QDs. Green: Golgi apparatus, Red: lactosylated QDs.  
 
 
Figure 3.15. 3-D maximum project image used to investigate colocalization between the 
Golgi apparatus and unconjugated QDs. Green: Golgi apparatus, Red: lactosylated QDs 
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Figure 3.16. 3-D maximum project image used to investigate colocalization between the 
nuclear envelope and lactosylated QDs. Green: nuclear envelope. Red: QDs. 
 
 
Figure 3.17. 3-D maximum project image used to investigate colocalization between the 
Golgi apparatus and unconjugated QDs. Green: nuclear envelope. Red: QDs. 
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Figure 3.18. 3-D maximum project image used to investigate colocalization between the 
early endosomes and lactosylated QDs. Green: early endosomes. Red: QDs. 
 
 
Figure 3.19. 3-D maximum project image used to investigate colocalization between the 
early endosomes and unconjugated QDs. Green: early endosomes. Red: QDs. 
 
QDs (Figure 3.20). These values are too close to determine if the lactosylation of QDs 
caused a change in trafficking to the Golgi apparatus. M1 values for colocalization 
between QDs and the nuclear envelope were 0.963 ± 0.019 and 0.860 ± 0.093 for non-
lactosylated and lactosylated QDs, respectively. Again, these values are too close to 
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accurately conclude lactose effectively targeted the QDs toward the nucleus. Manders’ 
values for colocalization between the QDs and the early endosomes were calculated as 
0.304 ± 0.083 and 0.285 ± 0.114 for the non-lactosylated and lactosylated QDs, 
respectively. These values also offered no further evidence that the lactosylated QDs 
were trafficked differently than non-lactosylated QDs.  
 
 
 
Figure 3.20. Comparison of M1 Values. Graph showing M1 values and standard 
deviation for each organelle.  
 
3.5 Conclusion and Future Work 
 This work explored the possibility of using lactosylated QD vectors as non-viral 
gene therapy vectors. Initial work was successful in optimizing water solubility 
techniques, functionalization with PEG derivatives, and bioconjugation of lactose. The 
ligand exchange solubilization produced QDs that were far more stable overtime than 
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previously used polymer encapsulated QDs. Imparting a positive charge on the QDs 
proved to be more difficult than previously expected. Similar work was done in the lab 
previously in an attempt to impart positive charge on polymer-encapsulated QDs, but 
inconclusive results were obtained in attempts to functionalize QDs with positive charge 
using QDs solubilized with MUA. Analysis of the imaging data seems to conclude there 
is not difference in trafficking between the lactosylated and non-lactosylated QDs. The 
bleed through between the red and green channels didn’t allow for conclusive 
colocalization to be determined. Comparison of M1 values between the lactosylated and 
non-lactosylated QDs, even with the bleed over, are too similar to come to a conclusion.  
Further work needs to be done optimizing the diamine reactions to produce an 
overall positive charge on the QDs. A molecule such as poly-arginine could be used to 
increase the overall positive charge. Intracellular trafficking experiments were completed 
using both conventional and confocal microscopy but need to be revisited using a 
different filter combination to produce usable results.  
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